GUSELKUMAB: DESCRIPTION OF CARDIOVASCULAR RISK AND EFFICACY IN PSORIASIS AND PSORIATIC ARTHRITIS IN REAL CLINICAL PRACTICE

被引：0
|
作者：
Gilabert, A. Navarro [1 ]
Andujar, S. Rufian [2 ]
Gil, A. Perez [1 ]
Perez, C. Azabal [3 ]
Hernandez, R. [3 ]
机构：
[1] Hosp Valme, Dermatol, Seville, Spain
[2] Hosp Valme, Cardiol, Seville, Spain
[3] Hosp Valme, Rheumatol, Seville, Spain
来源：
ANNALS OF THE RHEUMATIC DISEASES | 2022年 / 81卷
关键词：
D O I：
10.1136/annrheumdis-2022-eular.849
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
AB0882
引用
下载
收藏
页码：1564 / 1564
页数：1
相关论文
共 50 条
  • [1] EFFICACY AND SURVIVAL OF APREMILAST IN PATIENTS WITH PSORIATIC ARTHRITIS AND PSORIASIS IN REAL CLINICAL PRACTICE
    Anon Onate, I.
    Perez Galan, M. J.
    Romero, A.
    Aceituno, P.
    ANNALS OF THE RHEUMATIC DISEASES, 2020, 79 : 1657 - 1658
  • [2] CARDIOVASCULAR RISK IN PSORIASIS AND PSORIATIC ARTHRITIS
    McInnes, Iain
    ANNALS OF THE RHEUMATIC DISEASES, 2019, 78 : 3 - 3
  • [3] Guselkumab effectiveness and survival in patients with psoriasis and psoriatic arthritis: Multicenter analysis in daily clinical practice by the Spanish Psoriasis Group
    Rocamora, Vicenc
    Crespi, Laura
    Ferran, Marta
    Llamas-Velasco, Mar
    del Alcazar, Elena
    Carrascosa, Jose M.
    Beltran, Emma
    Urruticoechea-Arana, Ana
    Estebaranz, Jose Luis Lopez
    Vidal, David
    Riera, Josep
    Rodriguez, Lourdes
    Armesto, Susana
    Fernandez, Josep M.
    Aparicio, Gloria
    Perez, Silvia
    Porcar, Saray
    Montesinos, Encarna
    Gallardo, Fernando
    DERMATOLOGIC THERAPY, 2022, 35 (11)
  • [4] Psoriasis, psoriatic arthritis and cardiovascular risk: are we closer to a clinical recommendation?
    Kristensen, Soren Lund
    McInnes, Iain B.
    Sattar, Naveed
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 (02) : 321 - 322
  • [5] Real-life efficacy of guselkumab in patients with early psoriatic arthritis
    Pantano, Ilenia
    Mauro, Daniele
    Romano, Francesca
    Gambardella, Alessio
    Valenti, Mario
    Simone, Davide
    Iacono, Daniela
    Costanzo, Antonio
    Argenziano, Giuseppe
    Ciccia, Francesco
    RHEUMATOLOGY, 2022, 61 (03) : 1217 - 1221
  • [6] Psoriasis Drug Guselkumab Improved Psoriatic Arthritis Symptoms
    Slomski, Anita
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2020, 323 (20): : 1999 - 1999
  • [7] Paradoxical psoriatic arthritis in a patient with psoriasis treated with guselkumab
    Carriero, Antonio
    Lubrano, Ennio
    Picerno, Valentina
    Padula, Angela Anna
    D'Angelo, Salvatore
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (04) : 783 - 785
  • [8] Cardiovascular risk factors in psoriatic disease: psoriasis versus psoriatic arthritis
    Barbarroja, Nuria
    Arias-de la Rosa, Ivan
    Lopez-Medina, Clementina
    del Rosario Camacho-Sanchez, Maria
    Gomez-Garcia, Ignacio
    Jose Velez-Garcia, Antonio
    Escudero-Contreras, Alejandro
    Lopez-Pedrera, Chary
    Dolores Lopez-Montilla, Maria
    Collantes-Estevez, Eduardo
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2019, 11
  • [9] ANALYSIS OF THE EFFECTIVENESS AND SAFETY OF GUSELKUMAB IN REAL CLINICAL PRACTICE AFTER 2 YEARS OF TREATMENT IN PSORIATIC ARTHRITIS
    Perez Galan, M. J.
    Martin Martin, I
    Ruiz del Valle, V.
    Caro Hernandez, C.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2024, 42 (09) : 96 - 97
  • [10] Comment on: 'Paradoxical psoriatic arthritis in a patient with psoriasis treated with guselkumab'
    Akturk, Semra
    Altunisik, Nihal
    Buyukavci, Raikan
    Turkmen, Dursun
    CLINICAL AND EXPERIMENTAL DERMATOLOGY, 2022, 47 (07) : 1363 - 1364
12345